INSIGHTS

Research and practical buying guidance.

Browse practical buyer, technical, regulatory and evidence-led guidance across the VEMERIX knowledge library.

LATEST ARTICLES

Practical guidance from the VEMERIX team.

VEMERIX regulatory guide cover showing the Saudi Arabia medical device market placement workflow: SFDA MDMA under Law M/54, MDS-G008 risk classification (Classes A–D), May 2025 fee schedule, MDS-G028 bundling rules (3 May 2026), Authorized Representative mandate via GHAD, and MDS-REQ 5 shipment clearance.
How to Place a Medical Device on the Saudi Market in 2026: MDMA versus Authorized Representative versus Establishment License, SFDA Classes A–D, 2025 Fees, and the May 2026 Bundling RulesAn operational decision guide for international distributors, private-label/OEM buyers, and overseas manufacturers: navigating the Kingdom of Saudi Arabia's MDMA requirements under Law M/54, the Technical File Assessment route, SFDA Classes A–D (MDS-G008), the May 2025 fee schedule, the 3 May 2026 bundling criteria (MDS-G028), Authorized Representative mandates, importer establishment licensing, and port-clearance verification.August 25, 2026 · 18 min read
VEMERIX technical guide cover showing sterile hypodermic needle specification and incoming acceptance workflow: ISO 7864 dimensions, ISO 9626 tubing, ISO 6009 colour coding, ISO 80369-7 Luer fit, FDA product code FMI 510(k) verification, and China Class III NMPA evidence pack.
Sterile Hypodermic Needle Specification and Incoming Acceptance: ISO 7864 Dimensions, ISO 9626 Tubing, ISO 6009 Colour Coding, Luer Fit, and the FDA FMI / China Class III Evidence PackA specification and lot-acceptance guide for sterile single-use hypodermic needles: mapping ISO 7864, ISO 9626 tubing, ISO 6009 colour coding, ISO 80369-7 Luer fit, FDA product code FMI 510(k) evidence, China Class III registration requirements, and the GB 15811-2025 transition timeline.August 24, 2026 · 19 min read
VEMERIX regulatory guide cover showing the Great Britain medical device market placement workflow: CE recognition timelines to 2028 and 2030, UKCA requirements under UK MDR 2002, UK Responsible Person mandates, MHRA DORS registration and 2026 annual fees, post-market surveillance rules in force from June 2025, and the Northern Ireland EUDAMED framework.
How to Place a Medical Device on the Great Britain Market in 2026: When a Valid CE Mark Is Enough, When UKCA Is Required, Appointing a UK Responsible Person, MHRA Registration, and the June 2025 PMS Rules That Already ApplyAn operational decision guide for international distributors, OEM buyers, and non-UK manufacturers: navigating Great Britain's CE-recognition timelines (2028 vs 2030), UKCA requirements under UK MDR 2002, UK Responsible Person mandates, DORS registration and 2026 fees, Northern Ireland EUDAMED rules, and the in-force June 2025 post-market surveillance obligations.August 23, 2026 · 19 min read
VEMERIX technical guide cover showing the step-by-step review workflow for medical device ISO 10993 biological evaluation files, contact endpoints, the 2025 edition transition to 2029, and US/EU/China acceptance checks.
How to Review a Supplier's ISO 10993 Biocompatibility File: Endpoints by Contact and Duration, the 2025 Edition Transition (FDA Deadline July 2029), and a US/EU/China Acceptance ChecklistA practical buyer's audit guide for medical device biological safety files: matching endpoints to contact category and duration, verifying test-article final form, navigating the ISO 10993-1:2025 transition across FDA, EU MDR and China NMPA, and spotting disqualifying file gaps.August 22, 2026 · 18 min read
VEMERIX regulatory guide cover showing the step-by-step verification workflow for medical device Certificates of Free Sale, FDA FECV validation, EU MDR Article 60 requirements, UK MHRA checks, and China NMPA export certificate rules.
How to Verify a Certificate of Free Sale for a Medical Device: A Distributor's Guide to CFS and Export Certificates, Checking Issuing Authorities (FDA, EU, UK MHRA, NMPA) and Spotting Red FlagsA practical field-by-field verification guide for medical device export certificates: authenticating FDA CFGs via FECV, validating EU MDR Article 60 certificates, checking UK MHRA free-sale documents, navigating China's May 2026 export certificate reforms, and matching scope to your RFQ.August 21, 2026 · 19 min read
Sterile single-use medical catheter securement device with hypoallergenic adhesive pad and mechanical retainer clip securing an intravenous catheter on a clinical workstation.
What the FDA MAUDE and Recall Record Reveals About Catheter and Tube Securement Device Failures: A Post-Market Evidence Map for Securement Procurement and Supplier Screening (2015–2026)An original FDA post-market surveillance analysis of 1,125 MAUDE medical device reports, a 20-action recall record, and the 510(k)-exempt Class I regulatory baseline (21 CFR 880.5210, product codes KMK, CBH, OKC) translated into tender specifications, acceptance testing, and supplier-screening criteria for vascular-access and catheter-fixation procurement.August 14, 2026 · 16 min read
Sterile disposable surgical stapler and cartridge reload laid out on a clinical workstation surface.
What the FDA MAUDE and Recall Record Reveals About Surgical Stapler Failures: A Post-Market Evidence Map for Surgical Stapler Procurement and Supplier Screening (2015–2026)An original FDA post-market surveillance analysis of 3,645 MAUDE medical device reports, Class I/II recalls, and the 2021 Class II reclassification order (21 CFR 878.4740, product code GAG) translated into tender specifications, acceptance testing, and supplier-screening criteria for disposable surgical and circumcision stapler procurement.August 13, 2026 · 16 min read
FDA surveillance analysis diagram showing circumcision device 510(k) classification structure, HFX vs QQR MAUDE report distribution, and recall failure modes.
What the FDA MAUDE and Recall Record Reveals About Circumcision Device Failures: A Post-Market Evidence Map for Circumcision Procurement and Supplier Screening (2015–2026)An original FDA surveillance analysis of 31 circumcision device 510(k) clearances, 34 recalls, and 942 MAUDE adverse-event reports (all-time; 592 in the 2015–2026 window) translated into tender acceptance criteria and supplier-vigilance questions for disposable circumcision stapler, ring, and clamp devices.August 11, 2026 · 16 min read
Component mechanics, sterile kit components, and lot-acceptance testing framework for disposable circumcision anastomat and stapler devices.
Disposable Circumcision Anastomat and Stapler: Device Mechanics, Sterile-Kit Components and Lot-Acceptance Tests for Procurement and Biomedical EngineeringA component-level technical guide to the single-use circumcision anastomat and stapler: the bell-and-staple firing mechanism, what belongs in the sterile convenience kit, the staple-formation and sterile-barrier lot-acceptance tests, and the US, EU and China classification — including why no US 510(k) predicate and no WHO prequalification exist for the stapler.August 9, 2026 · 18 min read
Single-Use vs Reusable NPWT Pump Procurement Decision Matrix comparing FDA Class II product codes OMP, OKO, QPX, and QFC
Single-Use vs Reusable NPWT Pump: A Disposable-vs-Powered Procurement Decision Matrix Built on FDA Product Codes, HCPCS Reimbursement and Per-Episode CostThe FDA itself splits NPWT into reusable powered, non-powered mechanical and disposable powered single-use pumps under three different Class II product codes, and the right buy flows from exudate volume, wound complexity, care setting and reimbursement path rather than a blanket claim that disposable is better.August 8, 2026 · 16 min read
VEMERIX report cover showing thermal vs non-thermal varicose vein ablation regulatory ladder and supplier qualification framework.
Thermal vs Non-Thermal Varicose Vein Ablation: A Vascular Service-Line and Distributor Technology-Selection and Supplier-Qualification Guide (EVLA Laser Fiber vs RFA vs MOCA vs Cyanoacrylate Closure)Thermal (EVLA, RFA) and non-thermal (MOCA, cyanoacrylate closure) varicose-vein ablation platforms sit on different regulatory rungs. EVLA laser fibers (FDA GEX, Class II 510(k)) and RFA/MOCA catheters (GEI/KRA, Class II 510(k)) clear by substantial equivalence, while cyanoacrylate vein closure (VenaSeal, PJQ, Class III PMA) is a single-manufacturer PMA device with zero 510(k) predicates. Evaluate regulatory fit, supplier evidence packs, and consumable workflow economics alongside clinical closure data before committing portfolio or RFQ volume.August 7, 2026 · 16 min read